OpenLegislation

Part 2 Derogations from some of the requirements in Part 1

United Kingdom

  1. 6Scope
  2. 7Bibliographic application
  3. 8Application for a product using a new combination of active substances
  4. 9Application using existing data
  5. 10Application for a generic veterinary medicinal product
  6. 10AHybrid veterinary medicinal products
  7. 11Time limits for marketing authorisations granted under the procedure for a generic veterinary medicinal product
  8. 12Extension of time limits
  9. 12ATime limits – supplementary
  10. 13Parallel imports
  11. 14Specific batch control scheme
  12. 15Similar immunological products
  13. 16Marketing a product authorised in another country

Notes on Schedule 1

Textual amendments

F1

Words in Sch. 1 heading inserted (E.W.S.) (31.12.2020) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(b), 4(7)(a)

F2

Words in Sch. 1 heading inserted (N.I.) (31.12.2020) by The Animals (Health, Identification, Trade and Veterinary Medicines) (Amendment) (EU Exit) Regulations (Northern Ireland) 2020 (S.R. 2020/353), regs. 1(3), 10(13)(a)